etrasimod

Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
Fierce Pharma
Fri, 10/13/23 - 10:35 am
Bristol Myers Squibb
Zeposia
Pfizer
Velsipity
etrasimod
ulcerative colitis
FDA
Pfizer’s etrasimod aims to differentiate UC market with strong safety profile
Clinical Trials Arena
Fri, 05/26/23 - 11:12 am
Pfizer
etrasimod
ulcerative colitis
Pfizer kicks newly acquired meds out of Arena as part of midstage cleaning
Fierce Biotech
Tue, 05/2/23 - 11:22 pm
Pfizer
Arena Pharmaceuticals
etrasimod
M&A
Why This Promising Drug Will Be Pfizer's Next Blockbuster
Motley Fool
Sun, 07/10/22 - 11:53 pm
Pfizer
etrasimod
ulcerative colitis
Pfizer ulcerative colitis drug leads to remission in a third of patients -study
Reuters
Tue, 05/24/22 - 04:43 pm
Pfizer
ulcerative colitis
etrasimod
clinical trials
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
Motley Fool
Wed, 04/6/22 - 11:52 am
Pfizer
M&A
Arena Pharmaceuticals
etrasimod
clinical trials
ulcerative colitis
Pfizer's $7B ulcerative colitis drug racks up another phase 3 win, laying the groundwork for approval filings
Fierce Biotech
Tue, 03/29/22 - 10:50 am
Pfizer
ulcerative colitis
etrasimod
Arena Pharmaceuticals
clinical trials
Data and regulatory roundup: Pfizer’s feat, an ADHD miss, Eli Lilly’s CRL & more
MedCity News
Mon, 03/28/22 - 10:17 am
FDA
Pfizer
etrasimod
Argenxy
efgartigimod
Aligos Therapeutics
Vallon Pharmaceuticals
Adderall
ORIC Pharmaceuticals
ORIC-101
Neurana Pharmaceuticals
tolperisone
Eli Lilly
sintilimab
The first big test of Pfizer’s Arena buyout clears a PhIII in bid to catch up to Zeposia
Endpoints
Wed, 03/23/22 - 10:56 am
Pfizer
Zeposia
Bristol Myers Squibb
Arena Pharmaceuticals
etrasimod
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
Sat, 01/22/22 - 02:20 pm
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
10 clinical trials to watch in the first half of 2022
BioPharma Dive
Mon, 01/3/22 - 10:46 am
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Sanofi
GSK
vaccines
COVID-19
Roche
gantenerumab
AbbVie
Gilead Sciences
Trodelvy
Karuna Therapeutics
KarXT
Intercept Pharma
obeticholic acid
Allogene
ALLO-501a
Arena, completing its turnaround, sells to Pfizer for nearly $7 billion
BioPharma Dive
Mon, 12/13/21 - 11:08 am
Pfizer
M&A
Arena Pharmaceuticals
inflammation
etrasimod
Arena's lead drug misses on PhII in AD, thwacking stock, but company soldiers on into Phase III
Endpoints
Mon, 11/9/20 - 09:00 pm
Arena Pharmaceuticals
etrasimod
clinical trials
atopic dermatitis
Arena doses first subject in ELEVATE UC 12 phase 3 trial of Etrasimod in ulcerative colitis
Pharmaceutical Business Review
Mon, 09/28/20 - 10:52 am
Arena Pharmaceuticals
clinical trials
etrasimod
ulcerative colitis
3 Biotech Stocks That Skyrocketed This Week
Motley Fool
Sun, 03/25/18 - 11:29 am
biotech
Geron
imetelstat
Arena Pharmaceuticals
etrasimod
Heron Therapeutics
HTX-011
Arena Pharmaceuticals Takes Aim at Celgene
Motley Fool
Fri, 03/23/18 - 09:35 pm
Arena Pharmaceuticals
Celgene
etrasimod
ozanimod
ulcerative colitis
Here's Why Arena Pharmaceuticals, Inc. Surged Again on Wednesday
Motley Fool
Wed, 03/21/18 - 11:40 pm
Arena Pharmaceuticals
etrasimod
ulcerative colitis
Arena Pharmaceuticals Takes a Big Step Forward
Motley Fool
Tue, 03/20/18 - 09:43 am
Arena Pharmaceutical
etrasimod
ulcerative colitis
clinical trials
Celgene's Future Growth Could Depend on a Competitor's Trial This Quarter
Motley Fool
Wed, 02/14/18 - 11:20 am
Celgene
etrasimod
ozanimod
Arena Pharmaceuticals
MS
multiple sclerois